Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Sonazoid in Healthy Volunteers
NCT03340870Phase 1Completed
- Sponsor
- GE HealthCare
- Start
- Oct 2014
- Primary completion
- Nov 2014
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label trial of sonazoid in focal liver lesions (FLLs) (2 arms), sponsored by GE HealthCare. Primary endpoints: Area Under the Concentration Versus Time Curve from Time Zero to the Last Time-Point in Blood at 4 hours, Area Under the Concentration Versus Time Curve from Time Zero to Infinity in Blood at 4 hours and 14 more. Started Oct 2014; status: completed.
02
Drugs
sonazoid
03
Conditions
focal liver lesions (FLLs)
Beyond the preview
Go deeper on NCT03340870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340870.